RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

Post-Summit-launch-header

Highlights from the first-ever WFH Global Summit on WGBDs

Over a year ago, a seed was planted to organize a global summit for women and girls with bleeding disorders (WGBDs). That seed came to fruition this past November when the WFH held the first-ever Global Summit on women and girls with inherited bleeding disorders.

Also available in: Français

Over a year ago, a seed was planted to organize a global summit for women and girls with bleeding disorders (WGBDs). That seed came to fruition this past November when the WFH held the first-ever Global Summit on women and girls with inherited bleeding disorders. Because of the COVID-19 pandemic the event was held virtually—but that didn’t stop it from being dynamic, creative, and inspiring for all who attended in a global show of solidarity and empowerment. Nearly 1,400 participants from all corners of the world registered for the event—helping to make it a major success.

The Summit kicked off with an address from Cesar Garrido, WFH President, who emphasized the need for inclusion. Gina Schnabel—daughter of Frank Schnabel, founder of the WFH—then shared her story as a carrier. In her opening video, she declared, “You are your most powerful ally, never stop speaking up”, which set the tone for the next two days. Dawn Rotellini, Chair of the WFH Women with Inherited Bleeding Disorders Committee, shared data from the 2019 WFH Annual Global Survey related to women; she also shared information on actions the WFH has taken to serve female patients. Other sessions from the Summit began with testimonials from women who discussed how living with a bleeding disorder has shaped their lives.

Quality of life and the impacts of a bleeding disorder on women and girls was discussed in the first session of the Summit. The session outlined the numerous challenges women and girls face due to heavy menstrual bleeding and the fact that their condition is often dismissed by physicians.

The diagnosis dilemma—and the challenges it poses in both developed and developing countries—was addressed by Robert Sidonio, MD. What is considered normal bleeding was looked at by Michelle Lavin, MD, who mentioned the term, “menstrual blindness” which describes the fact that often, female patients do not recognize in themselves symptoms of having a bleeding disorder, such as excessive menstrual bleeding. Lavin went on to cover the importance of monitoring and tracking periods and other bleeding-disorders-related symptoms. Roshni Kulkarni, MD, an expert in telemedicine, illustrated opportunities for reaching and treating patients who live in remote areas far from treatment centres—thus giving patients hope and offering them counsel on care and treatment options and during today’s pandemic conditions.

The exchanges in the session on what women need and want were powerful, allowing both treaters and patients to dive deep into how to change the current situation and respond to the needs of WGBDs.

The WFH launched its new Initiative for Women and Girls in a fun, interview-style session led by Sharon Caris, and featuring special guests Cesar Garrido, WFH President; former WFH president Mark Skinner; Jameela Sathar, MD, from Malaysia; and Luisa Durante on behalf of the WFH. This endeavour will focus on key areas such as training for health care professionals so they can provide comprehensive care for WGBD patients. The initiative will also offer recommendations to national member organizations (NMOs) on how to conduct outreach and awareness campaigns on issues such as early diagnosis, inclusion and impacts on WGBDs. It will also encompass knowledge exchanges as well as the sharing of best practices between healthcare professionals (HCPs), patients and NMOs.

The second day started with a deep and insightful conversation on stigma, cultural norms, and taboos—all of which are barriers that often prevent women and girls from accessing adequate care and treatment. There were exchanges on how to normalize talking about blood, and how to connect with other women and girls to break the marginalization that is often experienced by WGBDs.

Another session covered the concept that access to health care is a fundamental human right for everyone, and how one can advocate for adequate care and treatment. The International VWD guidelines were shown to be a great tool for health care professionals and patients alike for addressing this challenge. This session showed how patients were engaged in the development of the guidelines. It also offered attendees many tips—which can be applied in local contexts—to advocate for change for persons living with von Willebrand disease (VWD).

NMOs from Tunisia, Malaysia and Honduras shared the actions their organizations are taking for WGBDs to foster leadership, empowerment, and a sense of belonging.

The Summit also featured bleeding disorders trivia, which was offered as an amusing and interactive way to test knowledge and to identify areas where more work is needed.

Participants for the first-ever Global Summit on women and girls with inherited bleeding disorders came together as a global community to listen, to learn, to enhance empowerment and to encourage greater participation and inclusion of WGBDs in patient organizations. A shift has begun, where bleeding disorders are not automatically only associated with men, and where there is greater awareness that women bleed too.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.